Skip to main content

and
  1. Article

    Open Access

    Transplantation of umbilical cord-derived mesenchymal stem cells into the striata of R6/2 mice: behavioral and neuropathological analysis

    Huntington’s disease (HD) is an autosomal dominant disorder caused by an expanded CAG repeat on the short arm of chromosome 4 resulting in cognitive decline, motor dysfunction, and death, typically occurring 1...

    Kyle D Fink, Julien Rossignol, Andrew T Crane in Stem Cell Research & Therapy (2013)

  2. Article

    Open Access

    Reductions in behavioral deficits and neuropathology in the R6/2 mouse model of Huntington’s disease following transplantation of bone-marrow-derived mesenchymal stem cells is dependent on passage number

    Huntington’s disease (HD) is an autosomal dominant disorder caused by an expanded CAG repeat (greater than 38) on the short arm of chromosome 4, resulting in loss and dysfunction of neurons in the neostriatum ...

    Julien Rossignol, Kyle D Fink, Andrew T Crane in Stem Cell Research & Therapy (2015)

  3. Article

    Open Access

    Mesenchymal stem cell-based therapy for ischemic stroke

    Ischemic stroke represents a major, worldwide health burden with increasing incidence. Patients affected by ischemic strokes currently have few clinically approved treatment options available. Most currently a...

    Johnathon D. Anderson, Missy T. Pham, Zelenia Contreras in Chinese Neurosurgical Journal (2016)

  4. No Access

    Article

    A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer’s disease mice

    Deposition of amyloid beta protein (Aβ) is a key component in the pathogenesis of Alzheimer’s disease (AD). As an anti-amyloid natural polyphenol, curcumin (Cur) has been used as a therapy for AD. Its fluoresc...

    Panchanan Maiti, Tia C. Hall, Leela Paladugu in Histochemistry and Cell Biology (2016)

  5. No Access

    Article

    Zika virus induces astrocyte differentiation in neural stem cells

    Zika virus (ZIKV) is a rapidly emerging flavivirus that has been associated with a number of congenital neurological manifestations. Here, we show that ZIKV replicated efficiently in mouse neural stem cells (m...

    Olivia V. Lossia, Michael J. Conway, Maya O. Tree in Journal of NeuroVirology (2018)

  6. Article

    Open Access

    Rapid Detection of Zika Virus in Urine Samples and Infected Mosquitos by Reverse Transcription-Loop-Mediated Isothermal Amplification

    Infection with Zika virus (ZIKV) is of growing concern since infection is associated with the development of congenital neurological disease. Quantitative reverse transcription PCR (qRT-PCR) has been the stand...

    Laura E. Lamb, Sarah N. Bartolone, Maya O. Tree, Michael J. Conway in Scientific Reports (2018)

  7. Article

    Open Access

    A novel approach to label bone marrow-derived mesenchymal stem cells with mixed-surface PAMAM dendrimers

    Transplantation of mesenchymal stem cells has created enormous opportunities as a potential treatment for various diseases including neurodegenerative diseases. Given current techniques, such as Hoechst labeli...

    Nikolas Munro, Bhairavi Srinageshwar, Firas Shalabi in Stem Cell Research & Therapy (2019)

  8. No Access

    Article

    High concentration of topical amitriptyline for treating chemotherapy-induced neuropathies

    Chemotherapy-induced peripheral neuropathy (CIPN) is a devastating pain condition of cancer therapy that may force chemotherapy dose reduction or discontinuation. Since treatment options for CIPN are quite lim...

    Julien Rossignol, Benoit Cozzi, François Liebaert in Supportive Care in Cancer (2019)

  9. No Access

    Article

    Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry

    Systemic mastocytosis (SM) is frequently associated with eosinophilia. To examine its prevalence and clinical impact in all WHO classification-based subcategories, we analyzed eosinophil counts in 2350 mastocy...

    Hanneke C. Kluin-Nelemans, Andreas Reiter, Anja Illerhaus, Bjorn van Anrooij in Leukemia (2020)

  10. No Access

    Article

    Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis

    In the current classification of the World Health Organization (WHO), bone marrow mastocytosis (BMM) is a provisional variant of indolent systemic mastocytosis (ISM) defined by bone marrow involvement and abse...

    Roberta Zanotti, Massimiliano Bonifacio, Giuseppe Lucchini, Wolfgang R. Sperr in Leukemia (2022)

  11. No Access

    Article

    UBA1 gene mutation in giant cell arteritis

    Julien Rossignol, Christophe Marzac, Azeddine Dellal in Clinical Rheumatology (2022)

  12. Article

    Open Access

    French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes

    Eosinophilic-related clinical manifestations are protean and the underlying conditions underpinning eosinophilia are highly diverse. The etiological workup of unexplained eosinophilia/hypereosinophilia can be ...

    Matthieu Groh, Julien Rohmer, Nicolas Etienne in Orphanet Journal of Rare Diseases (2023)

  13. No Access

    Article

    Reduced peripheral blood dendritic cell and monocyte subsets in MDS patients with systemic inflammatory or dysimmune diseases

    Systemic inflammatory and autoimmune diseases (SIADs) occur in 10–20% of patients with myelodysplastic syndrome (MDS). Recently identified VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndr...

    Vincent Jachiet, Laure Ricard, Pierre Hirsch in Clinical and Experimental Medicine (2023)

  14. No Access

    Article

    Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee

    Systemic Mastocytosis (SM) is a multifaceted clinically heterogeneous disease. Advanced SM (AdvSM) comprises three entities: aggressive SM (ASM), mast cell leukaemia (MCL) and SM with an associated hematologic...

    Donal P. McLornan, Tomasz Czerw, Gandhi Damaj, Mark Ethell, Carmelo Gurnari in Leukemia (2024)